NCT03574558 - Personalized Automated Determination of Insulin Pump Setting for Subjects With Type 1 Diabetes Switching From MDI to Pump Therapy and Vice Versa- Safety and Efficacy Feasibility Study | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

August 1, 2018

Primary Completion Date

November 25, 2019

Study Completion Date

November 25, 2019

Conditions

Type1diabetes

Interventions

DEVICE

MD-Logic Switch Advisor

Study algorithm will be used in order to determine the initial pump setting/ MDI dosing while switching from from MDI to pump therapy or vice versa

Trial Locations (1)

Schnider children's medical center, Petah Tikva